Towerpoint Wealth, LLC Bristol Myers Squibb CO Transaction History

Towerpoint Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $4,862 - $5,757	71 Added 2.27%	3,193 $229,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $0 - $76	1 Added 0.03%	3,122 $222,000
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $145 - $159	-2 Reduced 0.06%	3,121 $240,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $192,002 - $230,227	3,123 New	3,123 $228,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $210,822 - $246,951	-3,563 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $21,420 - $23,327	346 Added 10.76%	3,563 $238,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $185,749 - $210,488	3,217 New	3,217 $200,000
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $149,268 - $216,922	-3,217 Closed	0 $0
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $158,308 - $206,499	3,217 New	3,217 $206,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Towerpoint Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Towerpoint Wealth, LLC with notifications on news.